Mostrando entradas con la etiqueta virología. Mostrar todas las entradas
Mostrando entradas con la etiqueta virología. Mostrar todas las entradas

lunes, 2 de mayo de 2011

Cultivo de Virus: Un enfoque práctico - Virus Culture: A Practical Approach (Practical Approach Series)

Cultivo de Virus: Un enfoque práctico - Virus Culture: A Practical Approach (Practical Approach Series)
Editorial: Oxford University Press | ISBN: 0199637148 | Edición 1999 | PDF | 291 páginas | 14,5 mb
Univ. de Leicester, Reino Unido. Describe la última metodología probada y comprobada para cultivo de virus. Paso a paso y protocolos de sugerencias y consejos para el éxito se proporcionan. ilustraciones de medios tonos se incluyen en el texto. Para los estudiantes y virólogos en la investigación académica, industrial y clínica.
Depodescarga aquí
turbodescarga aquí (Mirror)
filesodescarga aquí (Mirror)


Sin contraseña

sábado, 11 de septiembre de 2010

Virus Oncogénicos Humanos (2ª Edición) - Human Oncogenic Viruses (2nd Edition)

Jing-hsuin James Ou, T. S. Benedict Yen - Human Oncogenic Viruses (2nd Edition) - Virus Oncogénicos Humanos (2ª Edición)
World Scientific Publishing Company | ISBN: 9812833463 | 2009-12-21 | PDF | 352 pages | 7.17 Mb
Viruses are the causes of approximately 25 per cent of human cancers. Due to their importance in carcinogenesis, there is a desperate need for a book that discusses these viruses. This book is therefore timely, providing a comprehensive review of the molecular biology of oncogenic viruses and the cancers they cause. Viruses that are discussed in the individual chapters include hepatitis B virus, hepatitis C virus, human papilloma viruses, Epstein-Barr virus, Kaposi's sarcoma virus and human T-cell leukemia virus type 1. This book provides up-to-date information for graduate students, postdoctoral fellows, medical students, physicians and non-experts who are interested in learning more about the oncogenic viruses and how they cause human cancers.
Descarga aquí:
depoDownload HERE
filesodescarga aquí (Mirror)

sábado, 10 de julio de 2010

Introduction to Modern Virology (Dimmock, Introduction to Modern Virology)

Introduction to Modern Virology (Dimmock, Introduction to Modern Virology): Nigel Dimmock, Andrew Easton, Keith Leppard
Review
" This popular volume continues to be demanded by the many undergraduates in virology and related fields for which it was originally written ... I would certainly recommend this book to anyone needing an introduction to virology and in addition the book is a useful reference source for those who have been in the field for some years. " J Chemical Technology and Biotechnology on the third edition --This text refers to an out of print or unavailable edition of this title.
Product Description
Introduction to Modern Virology has been an established student text for over 25 years. Providing an integrated account of the subject across different host systems, with an emphasis on human and animal viruses, this book covers the field of virology from molecular biology to disease processes using a unique systems approach. Featuring an all new art program in full color, the new edition has been updated throughout, and reorganized into thematic sections on the fundamental nature of viruses, their growth in cells, their interactions with the host organism and their role as agents of human disease. There is a new chapter on Human Viral Disease and rapidly developing areas, such as the use of viruses as gene therapy vectors, have been included.
The 6th edition is even more accessible, now including key points and integrative questions in every chapter, as well as text boxes emphasizing take-home messages, evidence underpinning the main concepts, and further information for more advanced readers. Prevention and therapy, evolution and emerging viruses receive particular attention and specific chapters address the major infectious challenges posed by HIV, pandemic influenza and BSE. This highly accessible text provides ideal reading for all undergraduate and postgraduate students of biology and medicine wishing to study virology.
Artwork from the book and helpful student and instructor resources are available online at
Product Details
  • Paperback: 536 pages
  • Publisher: Wiley-Blackwell; 6 edition (January 22, 2007)
  • Language: English
  • ISBN-10: 1405136456
  • ISBN-13: 978-1405136457
Rar'd PDF ~ 5.1 MB's Bookmarked
sendDESCARGA AQUÍ
mediaDESCARGA AQUÍ (Mirror) 

sábado, 6 de marzo de 2010

Viral Hepatitis: Diagnosis, Treatment, Prevention - Hepatitis Virales: Diagnóstico, Tratamiento, Prevención


Viral Hepatitis: Diagnosis, Treatment, Prevention
Hepatitis Virales: Diagnóstico, Tratamiento, Prevención
Publisher: Informa Healthcare | ISBN: 0824794168 | edition 1997 | CHM | 532 pages | 10 mb
This up-to-date and informative guide covers the molecular biology, clinical description, immunopathogenesis, diagnostic testing methods, therapy, and prevention of the recognized forms of human viral hepatitis, acute and chronic.
Functional links. Enlaces funcionales / Status: Bajado.
depodescarga aquí/Download
turbodescarga aquí (mirror)
MGdescarga aquí (mirror)

miércoles, 6 de enero de 2010

HIV Interactions with Host Cell Proteins (Current Topics in Microbiology and Immunology) - Interacciones del VIH con las Proteínas de la Célula Huésped (Temas de Actualidad en Microbiología e Inmunología)

Paul Spearman, Eric O. Freed "HIV Interactions with Host Cell Proteins (Current Topics in Microbiology and Immunology)"
Interacciones del VIH con las Proteínas de la Célula Huésped (Temas de Actualidad en Microbiología e Inmunología)
Springer | English | 2009-12-14 | ISBN: 3642021743 | 204 pages | PDF | 2,6 MB
The authors seek to understand the assembly process of human immunodeficiency virus (HIV) and to develop a vaccine that can effectively neutralize HIV. HIV assembly is a process directed by the viral Gag polyprotein. Gag is a myristoylated precursor protein that is translated in the cytoplasm and then traffics to the plasma membrane or to endosomal vesicles for assembly. The authors have recently described an interaction between Gag and the delta subunit of the AP-3 adaptor protein complex (1). The mechanism and structural basis for this interaction is now under intense study. Our hypothesis is that the AP-3 interaction is responsible for the trafficking of Gag to the multivesicular body (MVB) and that this event is part of a normal productive particle assembly pathway. The Vpu protein of HIV assists the virus assembly process through a poorly-defined mechanism. The authors have presented evidence that Vpu overcomes a host cell restriction to assembly (2). Vpu appears to act through interactions with the recycling pathways in the cell, rather than directly interacting with Gag (3). The nature of the host restriction to assembly that Vpu overcomes is a focus of our ongoing work.
Enlaces funcionales. Functional links.

viernes, 1 de enero de 2010

Frontiers in Viral Hepatitis - Fronteras en la hepatitis viral



R.F. Schinazi, J.-P. Sommadossi, C. Rice "Frontiers in Viral Hepatitis"
"Fronteras en la hepatitis viral"
Elsevier Science | English | 2003-12-26 | ISBN: 0444509860 | 598 pages | PDF | 27,7 MB
Frontiers in Viral Hepatitis provides a compilation of the research from over 40 key opinion leaders in the field of Hepatitis. The book focuses on the latest advances in the search for new, more effective therapeutic options and related topics in viral hepatitis. These include regulatory issues, epidemiology, and emerging viruses; immunology and vaccines; viral hepatitis B and C infections in children; genetics pathology and viral diagnosis; cell systems and animal models; novel therapeutics for hepatitis B and C; resistance and therapeutic strategies in humans; and prevention and treatment options for hepatocellular carcinoma.
The breadth of information published in this volume provides insight into current prevention and treatment options. Recent advances in our understanding of the molecular biology, immunology and pathogenesis of hepatitis viruses have accelerated at a remarkable rate, offering a more comprehensive perspective on hepatitis.
Enlaces funcionales. Functionals links.

viernes, 20 de noviembre de 2009

The Pathological Protein: Mad Cow, Chronic Wasting, and Other Deadly Prion Diseases "El Mal de la Vaca Loca" Enfermedad de Creutzfeldt-Jakob

The Pathological Protein: Mad Cow, Chronic Wasting, and Other Deadly Prion Diseases (Creutzfeldt - Jakob disease)
The Pathological Protein: Mad Cow, Chronic Wasting, and Other Deadly Prion Diseases
Publisher: Springer | ISBN: 0387955089 | edition 2003 | PDF | 307 pages | 15,51 mb
In 1996, British doctors were horrified to discover that mad cow disease (BSE), an affliction that had been plaguing British cattle for ten years, had jumped the species barrier and was appearing in humans as variant Creutzfeldt-Jakob disease (vCJD). Not unlike the mad cows, victims of vCJD suffer from a degenerative neurological disease that peppers the brain with microscopic holes, causing dementia, loss of motor control, and certain death. What alarms researchers and public health officials worldwide is that the incubation period for vCJD may be as long as 10 or even 15 years, and during this period those infected are symptom-free. And because the disease is so far undetectable except by autopsy, there is no way of knowing with certainty how many people have already been infected. In fact, even travelers who spent time in the U.K. from the early 1980s through the mid-1990s are still considered to be at some risk. What's more, although the U.S. has not detected any mad cows within its borders, there are plenty of "mad deer" running free in several states, and the disease afflicting them is a BSE-type neurological disorder. Called chronic wasting disease (CWD), the illness in these deer has yet to be linked with any human deaths. But given BSE's ability to jump species, there are no guarantees.
4shadescarga aquí 
DepositfilesDescarga aquí
Fast- filedescarga aquí (mirror)
UploadingDescarga aquí (mirror)
MegaupDescarga aquí (mirror)

domingo, 15 de noviembre de 2009

Viral Membrane Proteins Structure, Function, and Drug Design - Proteínas de Membrana codificadas por Virus: Estructura, Función y Diseño de Drogas Blanco

Title: Viral Membrane Proteins:Structure, Function, and Drug Design



Proteínas que se observan en las membranas de los virus: Estructura, Función y Diseño de Drogas (lo que les otorgará especificidad para blanco o diana "target".)
Springer| ISBN 0306484951 | 2005-05-23 | PDF | 292 pages |4.56 MB

In Viral Membrane Proteins: Structure, Function, and Drug Design, Wolfgang Fischer summarizes the current structural and functional knowledge of membrane proteins encoded by viruses. In addition, contributors to the book address questions about proteins as potential drug targets. The range of information covered includes signal proteins, ion channels, and fusion proteins.
This book has a place in the libraries of researchers and scientists in a wide array of fields, including protein chemistry, molecular biophysics, pharmaceutical science and research, biotechnology, molecular biology, and biochemistry

lunes, 9 de noviembre de 2009

Enlace a la Universidad de Carolina del Sur, EE UU

Un enlace directo a una prestigiosa universidad que ofrece en línea una página con información gráfica interactiva a todo color sobre tópicos interesantes de microbiología, pasando por la inmunología y áreas relacionadas. Recomendada para visitarla, darle un vistazo, extraer material, complementar tus estudios, etc., enriquecer tu conocimiento. ¡Las páginas html ya no tienen contraseña para ingresar! ¡El ingreso es libre!, por eso disfrútalo.

sábado, 19 de septiembre de 2009

Antiviral Strategies (Handbook of Experimental Pharmacology)


RapidDescarga aquí
A crucial issue for antiviral therapy is the fact that all antiviral substances rapidly select for resistance; thus, monitoring and overcoming resistance has become a most important clinical paradigm of antiviral therapy. This calls for cautious use of antiviral drugs and implementation of combination therapies. In parallel, efforts in drug discovery have to be continued to develop compounds with novel mode-of-action and activity against resistant strains. This book reviews the current status of antiviral therapy, from the roads to development of new compounds to their clinical use and cost effectiveness. Individual chapters address in more detail all available drug classes and outline new approaches currently under development.